Joel Greenblatt's AUPH Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 168,598 shares of Aurinia Pharmaceuticals Inc. (AUPH) worth $2.5 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in AUPH, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 46,634 shares. Largest reduction occurred in Q2 2023, reducing 55,147 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Aurinia Pharmaceuticals (AUPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aurinia Pharmaceuticals (AUPH) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +41,211 | Add 32.35% | 168,598 | $14.82 |
| Q4 2025 | +46,634 | Add 57.75% | 127,387 | $15.95 |
| Q3 2025 | -7,738 | Reduce 8.74% | 80,753 | $11.05 |
| Q2 2025 | +5,455 | Add 6.57% | 88,491 | $8.47 |
| Q1 2025 | +38,040 | Add 84.54% | 83,036 | $8.04 |
| Q4 2024 | +3,655 | Add 8.84% | 44,996 | $8.98 |
| Q3 2024 | +1,049 | Add 2.60% | 41,341 | $7.33 |
| Q2 2024 | +40,292 | New Buy | 40,292 | $5.71 |
| Q3 2023 | -39,733 | Sold Out | 0 | $0.00 |
| Q2 2023 | -55,147 | Reduce 58.12% | 39,733 | $9.68 |
| Q1 2023 | +94,880 | New Buy | 94,880 | $10.96 |
Joel Greenblatt's Aurinia Pharmaceuticals Investment FAQs
Joel Greenblatt first purchased Aurinia Pharmaceuticals Inc. (AUPH) in Q1 2023, acquiring 94,880 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Aurinia Pharmaceuticals Inc. (AUPH) for 11 quarters since Q1 2023.
Joel Greenblatt's largest addition to Aurinia Pharmaceuticals Inc. (AUPH) was in Q1 2023, adding 94,880 shares worth $1.04 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 168,598 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $2.5 M.
As of the Q1 2026 filing, Aurinia Pharmaceuticals Inc. (AUPH) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Aurinia Pharmaceuticals Inc. (AUPH) was 168,598 shares, as reported at the end of Q1 2026.